| MeSH term | MeSH ID | Detail |
|---|---|---|
| Lung Neoplasms | D008175 | 171 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| MacNeil DJ et al. | Correlation of the avermectin polyketide synthase genes to the avermectin structure. Implications for designing novel avermectins. | 1994 | Ann. N. Y. Acad. Sci. | pmid:8010663 |
| Smith CB et al. | Mycoplasma pneumoniae infections in volunteers. | 1967 | Ann. N. Y. Acad. Sci. | pmid:4861142 |
| Godzeski CW et al. | The interaction of antibiotics, bacteria and the bacterial L-phase in vivo. | 1967 | Ann. N. Y. Acad. Sci. | pmid:4167700 |
| May EF and Calvert PC | Aggravation of myasthenia gravis by erythromycin. | 1990 | Ann. Neurol. | pmid:2252369 |
| SADE J | RETROGRADE FACIAL PARALYSIS. | 1965 | Ann. Otol. Rhinol. Laryngol. | pmid:14265638 |
| Shurin PA | Antibacterial therapy and middle ear effusions. | 1976 Mar-Apr | Ann. Otol. Rhinol. Laryngol. | pmid:1267355 |
| Takahashi Y et al. | Effects of indomethacin, dexamethasone, and erythromycin on endotoxin-induced intraepithelial mucus production of rat nasal epithelium. | 1997 | Ann. Otol. Rhinol. Laryngol. | pmid:9270434 |
| Karmody CS and Weinstein L | Reversible sensorineural hearing loss with intravenous erythromycin lactobionate. | 1977 Jan-Feb | Ann. Otol. Rhinol. Laryngol. | pmid:835977 |
| Axelsson A and Brorson JE | The concentration of antibiotics in sinus secretions. Ampicillin, cephradine and erythromycinestolate. | 1974 May-Jun | Ann. Otol. Rhinol. Laryngol. | pmid:4829738 |
| Kobayashi T et al. | Ototoxic effect of erythromycin on cochlear potentials in the guinea pig. | 1997 | Ann. Otol. Rhinol. Laryngol. | pmid:9228863 |
| Kirtsreesakul V et al. | Microbiology and antimicrobial susceptibility patterns of commensal flora in the middle nasal meatus. | 2008 | Ann. Otol. Rhinol. Laryngol. | pmid:19140538 |
| Fensterbank R | Selection and characterization of a Listeria monocytogenes vaccinal strain of reduced virulence for mice. | 1986 | Ann. Rech. Vet. | pmid:3096186 |
| Fensterbank R | Vaccination against Listeria infection in mice with a mutant strain of reduced virulence. | 1986 | Ann. Rech. Vet. | pmid:3096187 |
| Devriese LA | Sensitivity of staphylococci from farm animals to antibacterial agents used for growth promotion and therapy. A ten year study. | 1980 | Ann. Rech. Vet. | pmid:7337397 |
| Escoula L et al. | [Bioavailability of erythromycin and colistin in calves (author's transl)]. | 1981 | Ann. Rech. Vet. | pmid:7344563 |
| Devriese LA | In vitro susceptibility and resistance of animal staphylococci to macrolide antibiotics and related compounds. | 1976 | Ann. Rech. Vet. | pmid:136223 |
| SCHUBART AF et al. | EFFECT OF PENICILLIN TREATMENT ON SERUM COMPLEMENT LEVELS IN ACUTE RHEUMATIC FEVER. | 1963 | Ann. Rheum. Dis. | pmid:14059292 |
| Ford DK | Antibiotic treatment in Reiter's syndrome. | 1979 | Ann. Rheum. Dis. | pmid:263467 |
| Hawkins CF et al. | Detection by electron microscope of rod-shaped organisms in synovial membrane from a patient with the arthritis of Whipple's disease. | 1976 | Ann. Rheum. Dis. | pmid:64131 |
| Bartlett JG et al. | Veterans Administration Cooperative Study on Bowel Preparation for Elective Colorectal Operations: impact of oral antibiotic regimen on colonic flora, wound irrigation cultures and bacteriology of septic complications. | 1978 | Ann. Surg. | pmid:686893 |
| Yeo CJ et al. | Erythromycin accelerates gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. | 1993 | Ann. Surg. | pmid:8103982 |
| Becker JM and Alexander DP | Colectomy, mucosal proctectomy, and ileal pouch-anal anastomosis. A prospective trial of optimal antibiotic management. | 1991 | Ann. Surg. | pmid:1847796 |
| Nichols RL et al. | Efficacy of preoperative antimicrobial preparation of the bowel. | 1972 | Ann. Surg. | pmid:4562009 |
| Kaiser AB et al. | Cefoxitin versus erythromycin, neomycin, and cefazolin in colorectal operations. Importance of the duration of the surgical procedure. | 1983 | Ann. Surg. | pmid:6354113 |
| Nichols RL et al. | Effect of preoperative neomycin-erythromycin intestinal preparation on the incidence of infectious complications following colon surgery. | 1973 | Ann. Surg. | pmid:4743867 |
| Ohwada S et al. | Low-dose erythromycin reduces delayed gastric emptying and improves gastric motility after Billroth I pylorus-preserving pancreaticoduodenectomy. | 2001 | Ann. Surg. | pmid:11685031 |
| Jones FE et al. | Evaluation of "instant" preparation of the colon with povidone-iodine. | 1976 | Ann. Surg. | pmid:180916 |
| Roberts TL et al. | Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph. | 1979 | Ann. Surg. | pmid:443894 |
| Collard JM et al. | Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. | 1999 | Ann. Surg. | pmid:10077045 |
| KEFALIDES NA et al. | EVALUATION OF ANTIBIOTIC PROPHYLAXIS AND GAMMA-GLOBULIN, PLASMA, ALBUMIN AND SALINE-SOLUTION THERAPY IN SEVERE BURNS. BACTERIOLOGIC AND IMMUNOLOGIC STUDIES. | 1964 | Ann. Surg. | pmid:14138192 |
| Clarke JS et al. | Preoperative oral antibiotics reduce septic complications of colon operations: results of prospective, randomized, double-blind clinical study. | 1977 | Ann. Surg. | pmid:889372 |
| Korvick JA and Yu VL | Legionnaires' disease: an emerging surgical problem. | 1987 | Ann. Thorac. Surg. | pmid:3548617 |
| Cosgrove DM et al. | The management of Hemophilus influenzae, Type B, pericarditis. | 1976 | Ann. Thorac. Surg. | pmid:1083717 |
| Gonzalez-Lavin L and O'Connell TX | Mitral valve replacement with viable aortic homograft valves. | 1973 | Ann. Thorac. Surg. | pmid:4708287 |
| Gutschow CA et al. | Bile exposure of the denervated stomach as an esophageal substitute. | 2001 | Ann. Thorac. Surg. | pmid:11426748 |
| Fuller J et al. | Legionnaires' disease after heart transplantation. | 1985 | Ann. Thorac. Surg. | pmid:3885883 |
| RAVINA A | [Burns]. | 1962 | Annee Ther | pmid:13990817 |
| Hash JH | Antibiotic mechanisms. | 1972 | Annu Rev Pharmacol | pmid:4114184 |
| Khosla C et al. | Structure and mechanism of the 6-deoxyerythronolide B synthase. | 2007 | Annu. Rev. Biochem. | pmid:17328673 |
| O'Connor SE | Engineering of Secondary Metabolism. | 2015 | Annu. Rev. Genet. | pmid:26393965 |
| Linnemann CC and Nasenbeny J | Pertussis in the adult. | 1977 | Annu. Rev. Med. | pmid:324357 |
| Meyer RD and Finegold SM | Legionnaires' disease. | 1980 | Annu. Rev. Med. | pmid:6994607 |
| Grayston JT | Chlamydia pneumoniae, strain TWAR pneumonia. | 1992 | Annu. Rev. Med. | pmid:1580592 |
| Pestka S | Inhibitors of ribosome functions. | 1971 | Annu. Rev. Microbiol. | pmid:4949424 |
| Wagman GH and Weinstein MJ | Antibiotic from Micromonospora. | 1980 | Annu. Rev. Microbiol. | pmid:6159822 |
| Aharonowitz Y | Nitrogen metabolite regulation of antibiotic biosynthesis. | 1980 | Annu. Rev. Microbiol. | pmid:6108090 |
| Queener SW et al. | Mutants blocked in antibiotic synthesis. | 1978 | Annu. Rev. Microbiol. | pmid:81652 |
| Brown RD and Feldman AM | Pharmacology of hearing and ototoxicity. | 1978 | Annu. Rev. Pharmacol. Toxicol. | pmid:348060 |
| BATTERMAN RC et al. | Responsiveness of commonly encountered respiratory infections to oral administration of erythromycin. | 1956-1957 | Antibiot Annu | pmid:13425370 |
| LOPEZ-BELIO M et al. | Erythromycin in the bronchial tree after oral, intravenous, and aerosol administration. | 1956-1957 | Antibiot Annu | pmid:13425371 |
| MOURATOFF G et al. | The effectiveness of erythromycin for the treatment of chronic genitourinary infections. | 1956-1957 | Antibiot Annu | pmid:13425372 |
| JOHNSON SA et al. | Clinical observations on the use of erythromycin in acne vulgaris and some pyogenic skin eruptions. | 1956-1957 | Antibiot Annu | pmid:13425373 |
| TIDWELL RA and LEWIS D | The use of erythromycin as a prophylactic agent. | 1956-1957 | Antibiot Annu | pmid:13425374 |
| LEVINE ER and FROMAN A | The efficacy of erythromycin in respiratory infections. | 1956-1957 | Antibiot Annu | pmid:13425495 |
| FOX RT et al. | Clinical and laboratory experiences with erythromycin in treatment of thoracic empyema. | 1955-1956 | Antibiot Annu | pmid:13355244 |
| CALESNICK B | Effectiveness of oral erythromycin propionate in commonly occurring infections. | 1959-1960 | Antibiot Annu | pmid:13806941 |
| DAVIS DS et al. | The treatment of one hundred and seventy-one patients with erythromycin, including one hundred and thirty-two with bacterial pneumonia. | 1955-1956 | Antibiot Annu | pmid:13355245 |
| HAIGHT TH | Erythromycin therapy of venereal diseases, with especial reference to the comparative use of the oral and intramuscular preparations in acute gonococcal infections. | 1955-1956 | Antibiot Annu | pmid:13355342 |
| FRIEDMAN S et al. | A trial of erythromycin in rheumatic fever prophylaxis. | 1957-1958 | Antibiot Annu | pmid:13521807 |
| SHLAES WH et al. | Antibiotic diarrhea; effect of folic acid on erythromycin-induced diarrhea. | 1957-1958 | Antibiot Annu | pmid:13521874 |
| LOUGHLIN EH et al. | Antibiotic therapy of acute gonococcal infections; a study of the comparative efficacy of triacetyloleandomycin, erythromycin, and penicillin V in the treatment of acute gonococcal urethritis. | 1958-1959 | Antibiot Annu | pmid:13637747 |
| STEPHENS VC and CONINE JW | Esters of erythromycin. III. Esters of low molecular weight aliphatic acids. | 1958-1959 | Antibiot Annu | pmid:13637765 |
| LEE CC et al. | Pharmacology and toxicology of erythromycin propionate. | 1958-1959 | Antibiot Annu | pmid:13637766 |
| GRIFFITH RS | Laboratory and clinical studies with erythromycin propionate. | 1958-1959 | Antibiot Annu | pmid:13637767 |
| PERRY DM et al. | Clinical and laboratory studies of erythromycin propionate. | 1958-1959 | Antibiot Annu | pmid:13637768 |
| KUNIN CM et al. | Absorption of erythromycin propionate and triacetyloleandomycin. | 1958-1959 | Antibiot Annu | pmid:13637769 |
| METZGER WI et al. | Laboratory and clinical studies of intramuscular erythromycin. | 1958-1959 | Antibiot Annu | pmid:13637770 |
| MARMELL M et al. | Clinical trial of erythromycin propionate for acute anterior gonococcal urethritis. | 1959-1960 | Antibiot Annu | pmid:14421354 |
| REICHELDERFER TE et al. | Clinical studies of propionyl erythromycin lauryl sulfate in children. | 1959-1960 | Antibiot Annu | pmid:14437052 |
| SALITSKY S et al. | Erythromycin propionate: a clinical and laboratory study. | 1959-1960 | Antibiot Annu | pmid:14441020 |
| FORFAR JO and MACCABE AF | Erythromycin--a review. | 1957 | Antibiot Chemother | pmid:13488431 |
| Siegenthaler W et al. | [New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol]. | 1968 | Antibiot Chemother | pmid:4302993 |
| Schmid EE | The macrolide group of antibiotics. Mode of action. | 1971 | Antibiot Chemother (1971) | pmid:4951002 |
| Connamacher RH | Inducible bacterial resistance. | 1975 | Antibiot Chemother (1971) | pmid:773276 |
| Wilson JT and van Boxtel CJ | Pharmacokinetics of Erythromycin in man. | 1978 | Antibiot Chemother (1971) | pmid:27136 |
| Tanimoto H | A review of the recent progress in treatment of patients with diffuse panbronchiolitis associated with Pseudomonas aeruginosa infection in Japan. | 1991 | Antibiot Chemother (1971) | pmid:1801651 |
| WILLIAMSON GM and ZINNEMANN K | The susceptibility of coliform bacilli to erythromycin. | 1962 | Antibiot Chemother (Northfield) | pmid:14007243 |
| KIRBY WM et al. | Erythromycin serum concentrations following administration in acid-resistant tablets. | 1953 | Antibiot Chemother (Northfield) | pmid:24542409 |
| KIRSHBAUM A et al. | A cupplate method for the determination of erythromycin concentrations in serum and other body fluids. | 1953 | Antibiot Chemother (Northfield) | pmid:24542421 |
| CLARK RK | The chemistry of erythromycin. I. Acid degradation products. | 1953 | Antibiot Chemother (Northfield) | pmid:24542535 |
| MAPLE FM et al. | Serum concentrations of erythromycin following intravenous administration. | 1953 | Antibiot Chemother (Northfield) | pmid:24542586 |
| LEE CC et al. | Tissue distribution of erythromycin in rats. | 1953 | Antibiot Chemother (Northfield) | pmid:24542649 |
| SYLVESTER JC and JOSSELYN LE | Absorption of erythromycin. II. Erythromycin stearate. | 1953 | Antibiot Chemother (Northfield) | pmid:24542651 |
| GRIGSBY ME et al. | Some laboratory and clinical experiences with erythromycin. | 1953 | Antibiot Chemother (Northfield) | pmid:24542704 |
| LEE CC et al. | Site of absorption of erythromycin in rats. | 1954 | Antibiot Chemother (Northfield) | pmid:24543219 |
| MANTEN A | Synergism and antagonism between antibiotic mixtures containing erythromycin. | 1954 | Antibiot Chemother (Northfield) | pmid:24543317 |
| KUZEL NR et al. | Spectrophotometric determination of erythromycin in pharmaceutical products. | 1954 | Antibiot Chemother (Northfield) | pmid:24543318 |
| CLARK RK and TATERKA M | The chemistry of erythromycin. III. Acid degradation products of erythromycin B. | 1955 | Antibiot Chemother (Northfield) | pmid:24543468 |
| CLARK RK and FREIFELDER M | The synthesis of new erythromycins. | 1957 | Antibiot Chemother (Northfield) | pmid:24544531 |
| LEE CC et al. | Further pharmacological studies on propionyl erythromycin ester lauryl sulfate. | 1961 | Antibiot Chemother (Northfield) | pmid:13760219 |
| CLARK RK and VARNER EL | New esters of erythromycin. | 1957 | Antibiot Chemother (Northfield) | pmid:24544532 |
| MANIAR AC et al. | A comparison of the in vitro and in vivo activity of erythromycin and spiramycin. | 1960 | Antibiot Chemother (Northfield) | pmid:13766168 |
| ROBINSON MM | Demonstration by "challenge" of hepatic dysfunction associated with propionyl erythromycin ester lauryl sulfate. | 1962 | Antibiot Chemother (Northfield) | pmid:14492925 |
| GRIFFITH RS and BLACK HR | A comparison of blood levels after oral administration of erythromycin and erythromycin estolate. | 1962 | Antibiot Chemother (Northfield) | pmid:13901859 |
| GRIFFITH RS and BLACK HR | Comparison of antimicrobial activity of erythromycin estolate and demethylchlortetracycline against hemolytic streptococci. | 1962 | Antibiot Chemother (Northfield) | pmid:13901860 |
| CORDERO FA | Propionyl erythromycin ester lauryl sulfate in the treatment of treponematosis and chancroid. | 1961 | Antibiot Chemother (Northfield) | pmid:13881298 |
| STROM J | Penicillin and erythromycin singly and in combination in scarlatina therapy and the interference between them. | 1961 | Antibiot Chemother (Northfield) | pmid:13917845 |
| LIMSON BM | Lauryl sulfate salt of propionyl erythromycin: antibacterial activity in serum and therapeutic evaluation of low doses. | 1961 | Antibiot Chemother (Northfield) | pmid:14465340 |
| SALDANA TATE L | In vivo and in vitro evaluation of oleandomycin, erythromycin, and tetracycline against cultures of Staphylococcus aureus. | 1960 | Antibiot Chemother (Northfield) | pmid:14440930 |
| SCHNEIERSON SS et al. | Inhibition of Pseudomonas aeruginosa pigment formation by chloramphenicol and erythromycin. | 1960 | Antibiot Chemother (Northfield) | pmid:14443279 |